Abstract:C-C chemokine receptor 5 (CCR5) is the main HIV co-receptor affecting susceptibility and disease course. Quantitative trait loci (QTL) mapping analysis was performed to assess genetic variants associated with CCR5 expression on circulating immune cells in 209 PLHIV using ART and 304 healthy controls, all of Western European ancestry. The proportions of CCR5 positive cells and CCR5 mean fluorescence intensity (MFI) were assessed by flow cytometry in monocytes and CD4+ and CD8+ T cell subsets using flow cytometry. We identified the rs60939770, which is an intergenic variant in cis -region to CCR5 gene not in linkage disequilibrium with CCR5d32, related to the proportion of CCR5+ memory T regulatory cells, both in PLHIV and healthy controls. Two genome-wide significant loci, in linkage equilibrium with CCR5d32 , were found to be associated with CCR5 MFI of multiple subsets of mostly differentiated memory T cells in both groups. The expression of nearby chemokines receptors ( CCR1 , CCR2 , CCR3, CCRL2 ), existing in the same the same topologically associating domain, were also influenced by these genetic variants. Furthermore, we show the genetic variants which modulate CCR5 surface expression affect the production of other inflammatory mediators, including monocyte- and lymphocyte-derived cytokines as well as CCL4 and IL-8. Our data indicate that the genetic regulation of CCR5 expression is cell-specific and affects the production of various inflammatory mediators. Author Summary CCR5 plays a important role in the acquisition of HIV and it is associated to immune activation in people living with HIV (PLHIV). Using samples of cohorts composed of healthy individuals and PLHIV, we sought to map genomic regions that influence CCR5 expression on monocytes and subsets of CD4+ and CD8+ cells. We identified distinct genetic variants that are associated with CCR5 cell proportions or mean fluorescence intensity in subpopulations of T cells with memory functions in both healthy and PLHIV. The genetic variants also influenced the expression of other nearby chemokine receptors and the production of inflammatory mediators. Thus, we demonstrated that the genetic regulation of CCR5 expression is cell-type specific and may impact HIV susceptibility and disease progression. ### Competing Interest Statement The authors have declared no competing interest.

Toxicogenomics of the C–C chemokine receptor type 5 (CCR5): Exploring the potential impacts of chemical- CCR5 interactions on inflammation and human health

Chemokine Receptor Ccr5 Functionally Couples to Inhibitory G Proteins and Undergoes Desensitization

CCR5 and CCR5Δ32 in bacterial and parasitic infections: Thinking chemokine receptors outside the HIV box

CCR5 and Inflammatory Storm

CCL5/CCR5 axis in human diseases and related treatments

CCR5 is a potential therapeutic target for cancer

Human functional genomics reveals toxicological mechanism underlying genotoxicants-induced inflammatory responses under low doses exposure.

Host genetic variants regulates CCR5 expression on immune cells: a study in people living with HIV and healthy controls

Molecular determinants of antagonist interactions with chemokine receptors CCR2 and CCR5

Differential inflammatory responses triggered by toxic small molecules

Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis

C-X-C Chemokine Receptor Type 5 Gene Polymorphism Affects Gene Expression in CD4+ T Cells and is Associated with Increased Risk of Colorectal Cancer

CCR1 and CCR5 Expression on Inflammatory Cells is Related to Cigarette Smoking and Chronic Obstructive Pulmonary Disease Severity.

New Insights of CCR7 Signaling in Dendritic Cell Migration and Inflammatory Diseases

Chemokine receptors in COVID-19 infection

CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value

Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells

In Vitro Immunological Effects of Blocking CCR5 on T Cells

Chemokine receptor expression and modulation by Mycobacterium tuberculosis antigens on mononuclear cells from human lymphoid tissues

Exploring the CXCR3 Chemokine Receptor with Small-Molecule Antagonists and Agonists

Chemokine receptor hetero-oligomers regulate monocyte chemotaxis